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Abstract 
Background: The Surviving Sepsis Campaign and the American College of Critical Care Medicine guidelines have 
provided recommendations for the management of pediatric septic shock patients. We conducted a survey among 
the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) members to assess variations to these 
recommendations.
Methods: A total of 114 pediatric intensive care physicians completed an electronic survey. The survey consisted of 
four standardized clinical cases exploring seven clinical scenarios.
Results: Among the seven different clinical scenarios, the types of fluids were preferentially non-synthetic colloids 
(albumin) and crystalloids (isotonic saline) and volume expansion was not limited to 60 ml/kg. Early intubation for 
mechanical ventilation was used by 70% of the participants. Norepinephrine was stated to be used in 94% of the 
PICU physicians surveyed, although dopamine or epinephrine is recommended as first-line vasopressors in pediatric 
septic shock. When norepinephrine was used, the addition of another inotrope was frequent. Specific drugs such 
as vasopressin or enoximone were used in < 20%. Extracorporeal life support was used or considered by 91% of the 
physicians audited in certain specific situations, whereas the use of high-flow hemofiltration was considered for 44%.
Conclusions: This pediatric septic shock management survey outlined variability in the current clinician-reported 
practice of pediatric septic shock management. As most recommendations are not supported by evidence, these 
findings outline some limitation of existing pediatric guidelines in regard to context and patient’s specificity.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Sepsis and septic shock remain a major health problem 
in adults and children. Despite an increase in its inci-
dence, only moderate outcome improvements have been 
reported in critically ill pediatric patients with sepsis in 
the last decade [1]. Although the Surviving Sepsis Cam-
paign (SSC) [2, 3] and the American College of Critical 
Care Medicine (ACCM) [4, 5] have provided recommen-
dations for standardized sepsis management through 
early recognition and bundles of care, its current impact 
on mortality is questionable and variability of care has 
been shown [6–9]. The ACCM recommendations for 
hemodynamic support in pediatric septic shock, updated 
in 2014, have a number of important differences from the 
recent 2017 adult SSC recommendations [10] and may 
not be representative of current pediatric practices [11]. 
Importantly ACCM recommendations are context sensi-
tive and most of the time non-directive. We conducted a 
survey to assess the current clinician-reported practice of 
members of the European Society of Pediatric and Neo-
natal Intensive Care (ESPNIC).
Methods
This study was an ancillary analysis of a septic shock man-
agement Delphi study based on four clinical case scenar-
ios developed to compare management of patients with 
varying levels of shock and organ dysfunction (Additional 
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file  1). The survey was developed by a task force issued 
from the ESPNIC and especially from the Sepsis, infec-
tion and inflammation section. The characteristics of the 
clinical cases were set following a review of the literature 
on septic shock (with accordance to ACCM 2009) and 
a case analysis of septic shock patients, and covered the 
whole clinical spectrum of disease severity. Five mem-
bers from the task force (G.M., S.N., M.P., M.K., N.J.G.J.) 
reviewed the scenarios for consistency and objectivity.
Seven different clinical situations addressing key 
management interventions compared manage-
ment to published guidelines and are available in the 
attached Additional file 1 [12]. (A) Fluid resuscitation: a 
15-month-old boy had hypotension with clinical signs of 
circulatory dysfunction without signs of fluid overload. 
Participants were asked if they would pursue fluid expan-
sion or start an inotrope or a vasopressor. (B) Invasive 
mechanical ventilation: a 5-year-old child with purpura 
fulminans was admitted to PICU with a Glasgow Coma 
Scale of 10, no signs of respiratory failure but circulatory 
failure with fluid-refractory hypotension despite fluid 
expansion. Participants were asked if they would intubate 
the child as soon as admitted (while a third bolus was 
infused). (C–D) Vasopressor and inotrope use: an 8-year-
old girl was admitted in PICU for septic shock with com-
munity-acquired pneumonia. She had a central venous 
catheter and received 60 ml/kg of fluids in the emergency 
room and remained hypotensive with high blood lactate. 
Participants were asked if they would start a vasopres-
sor and/or inotrope. (E–F) Other inotropes or vasopres-
sors and adjunct therapies: an 8-year-old child had septic 
shock-related renal dysfunction with anuria and meta-
bolic acidosis requiring vasopressors and inotropes. 
Participants were asked if they would start continuous 
renal replacement therapy (CRRT). (G) Extracorpor-
eal Life Support (ECLS): participants were asked in dif-
ferent situations if they would start ECLS. We used the 
nomenclature from the ACCM for vasoactive drugs; 
norepinephrine, vasopressin and terlipressin were called 
vasopressors, whereas epinephrine, dopamine, dobu-
tamine, milrinone and enoximone were called inotropes. 
The first part of this questionnaire focused on routine use 
of therapeutics in pediatric septic shock patients (ranked 
from Never, Rarely, Often to Always). For adjunct thera-
peutics, responders were asked to grade their likelihood 
of use (0 = No to 10 = Yes) and considered a grade ≥ 8 
as formal agreement. The survey was sent to all ESPNIC 
members, and they were asked to forward the survey 
to their team. An internet-based survey service (Sur-
veyMonkey Inc., Palo Alto, California, USA) collected 
the answers. Due to the snowball sampling diffusion, 
we were not able to obtain the total number of physi-
cians who were approached with the survey, although 
the initial mail targeted 170 ESPNIC medical members. 
Frequencies and percentages or median and interquartile 
range (IQR) were used when appropriate to describe the 
responses. Data are presented as median [25–75 IQR] or 
number (percentage of total).
Results
From April 9 to July 2 2014, 114 physicians, represent-
ing 27 countries and > 80 pediatric intensive care units 
(PICUs), completed the survey. The geographic origin 
of the physicians was European in 79%, Asian, Oceanic, 
North American and African in 8%, 9%, 3% and 1%, 
respectively. 36% of physicians had < 10 years of experi-
ence, 44% had 10 to 20  years’ experience and 20% had 
more than 20  years’ experience. The affiliated PICUs 
admitted pediatric patients in 94%, neonates for 25% and 
cardiac patients for 42%. The median number of beds per 
PICU was 15 [10–21].
(A) Fluid resuscitation: more than 90% of the respond-
ents did not limit fluid expansion to 60 ml/kg and would 
administer a fourth fluid bolus if needed. The choice 
of the fluid was albumin (4% or 5%) for 43%, isotonic 
saline solution for 33%, Ringer lactate for 16% and syn-
thetic colloids for 8% of the respondents. (B) Invasive 
mechanical ventilation: the decision to intubate the child 
immediately was taken by 70% of the physicians. (C) 
Vasopressor: 88% of the respondents would start vaso-
pressor or inotrope immediately after admission, while 
12% would administer more fluids first. The first drug 
to be administered was norepinephrine (60%), epineph-
rine (25%), a combination of vasopressors and inotropes 
(22%), dobutamine (14%) and dopamine (13%). Outside 
these clinical scenarios, participants stated that dopa-
mine was used by 41% of them (15% systematically and 
25% often), while norepinephrine was used by 94% (56% 
systematically and 38% often) in a pediatric septic shock 
patient. (D) Inotropes: for 24% of the physicians, an ino-
trope (epinephrine, dobutamine or milrinone) should be 
used in all septic shock patients. Epinephrine was rou-
tinely used by 77% of the participants, while dobutamine 
and milrinone were used by 47% and 35%, respectively. 
In a clinical situation of shock with norepinephrine and 
normal blood pressure but high lactate and peripheral 
vasoconstriction, 38% of the physicians would add an 
inotrope (epinephrine by 22%, dobutamine by 13% and 
milrinone by 2%), while 54% would increase norepineph-
rine. (E) Other inotropes or vasopressors: in our survey, 
enoximone, terlipressin and methylene blue were never 
or rarely used by more than 96% of the responders. Only 
milrinone (35%) and vasopressin (20%) were always or 
often used in children with septic shock (Fig. 1). (F) High 
volume hemofiltration (HVHF), defined as CRRT with an 
ultrafiltrate rate above 35  mL/kg/h [13], was often used 
Page 3 of 6Morin et al. Ann. Intensive Care            (2019) 9:73 
by 28% of physicians in septic shock patients, while 36% 
never used this technique. In the clinical case depicting 
severe acute kidney injury in a septic shock child, most 
of the respondents would start CRRT (91%), with 48% of 
them choosing HVHF. (G) Extracorporeal Life Support 
among the 114 physicians audited, the majority (56%) 
had used venoarterial ECLS (VA-ECLS) in septic shock. 
Of the 45% who had not used it, 35% would consider this 
support if necessary. Physicians were most likely to con-
sider VA-ECLS during the clinical situations reported in 
Table 1. Situations in which clinicians were less likely to 
use VA-ECLS were persistent multi-organ failure 24  h 
after initial management and severe Acute Respiratory 
Distress Syndrome associated with septic shock.
Discussion
In this large survey targeting ESPNIC-affiliated pediat-
ric intensivists, we assessed clinician-reported practices 
in the management of children with septic shock. We 
found a high variability in clinical practice with some dis-
crepancy with current ACCM guidelines. In this survey, 
pediatric physicians used albumin as a volume expander 
despite a lack of evidence showing superiority over 
crystalloids in both adults [14] and children with septic 
shock [15]. The ACCM recommends their use without 
distinction [4, 5]. Balanced fluids were less used in this 
survey than isotonic saline solutions. A recent study 
reported lower rates of mortality or renal failure in adult 
patients requiring fluid expansion and ICU admission 
treated with balanced fluids compared to isotonic saline 
[16]. A pediatric study with a similar design is currently 
recruiting (PRoMPT BOLUS, NCT03340805). Regard-
ing fluid expansion, data on early goal directed therapy 
failed to demonstrate the superiority of liberal fluid 
boluses compared to usual treatment in adults (includ-
ing early aggressive fluid therapy and antibiotics) [6–8]. 
Pediatric restrictive versus liberal studies exist on pilot 
phase (SQUEEZE NCT03080038 and FISH [17] studies). 
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Fig. 1 Declared use of adjunct therapies in pediatric septic shock children
Table 1 Clinical situations most considered for  extra-corporeal life support in  pediatric septic shock (percent 
of responders grading ≥ 8/10)
Percentage
Severe myocardial dysfunction with left ventricular ejection fraction < 25% and cardiac index < 2.2L/min m2 72
Cardiac arrest despite PICU management 70
High blood lactates despite > 2mcg/kg min of norepinephrine 67
Persistence of septic shock with anuria, high blood lactates and high needs of vasopressors 24 h after initial management 64
Severe acute respiratory distress syndrome with septic shock 47
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Furthermore, retrospective data suggest an increased 
morbidity and mortality in children with a positive 
cumulative fluid balance in septic shock [18, 19]. A recent 
pediatric study demonstrated that a restrictive fluid 
strategy associated with early norepinephrine support is 
feasible and may improve the outcome of septic shock 
patients [20].
Despite being hypotensive and without severe neu-
rological nor respiratory distress, a prompt intubation 
and mechanical ventilation were decided as supported 
by a study describing a decrease in meningococcal dis-
ease mortality after the implementation of manage-
ment bundles including early intubation and mechanical 
ventilation following 40  ml/kg of fluid expansion [21]. 
Guidelines highlight the risk of vascular collapse during 
intubation in non-appropriately resuscitated patients. 
According to the ACCM, volume loading and periph-
eral or central inotropic/vasoactive drug support is rec-
ommended before and during intubation to overcome 
relative or absolute hypovolemia, cardiac dysfunction, 
and the risk of suppressing endogenous stress hormone 
response with agents that facilitate intubation [4, 5]. Fur-
thermore, the SSC recommends the use of either high-
flow nasal cannula oxygen or nasopharyngeal CPAP to 
increase functional residual capacity and reduce the work 
of breathing during the resuscitation phase, which is 
based on physiology given the absence of data on optimal 
respiratory management in septic shock in children [2].
Due to lack of evidence, the choice for the first-line ino-
trope or vasopressor was unclear in the 2009 version of 
the ACCM. The 2014 revision favors the use of epineph-
rine in cold shock and norepinephrine in or warm shock. 
Our survey revealed that norepinephrine represents 
the vasopressor of choice for many European pediatric 
intensivists. This result was consistent with adult recom-
mendations [2, 10]. Of note, the choice of vasopressor in 
children may vary depending on age and access, which 
our survey did not investigate. Currently, the only two 
controlled studies on this subject support the superiority 
of epinephrine to dopamine as first-choice vasopressor in 
pediatric septic shock [22]. Besides uncontrolled studies 
outlining the effect of norepinephrine in shock reversal 
irrespective of hemodynamics [20], no controlled study 
comparing norepinephrine to dopamine and/or epi-
nephrine exists in children. Since the administration of 
inotropes or vasopressors can be delayed while central 
venous access is obtained, the ACCM recommends start-
ing inotropes such as epinephrine (or dopamine) via a 
peripheral venous line in the meantime. Recent reports 
as well as the adult SSC support the feasibility and appar-
ent safety of norepinephrine when delivered through a 
peripheral line or intra-osseous catheter before central 
line placement [20, 23].
In pediatric septic shock patients, the occurrence of 
septic cardiomyopathy can impact the hemodynamic 
profile and prognosis and is known to be reversible in 
survivors of septic shock [24, 25]. In cases of myocar-
dial dysfunction, the ACCM recommends the use of 
inotropes to maintain cardiac output [5]. The choice of 
inotrope is controversial in both adults [26] and children 
[22, 27, 28], although addition of inotrope support in 
response to multimodal hemodynamic monitoring signif-
icantly decreased mortality in children in one study [29]. 
Understanding the heterogeneity of myocardial function 
may be important to select appropriate vasopressor or 
inotrope support in children in septic shock. The ACCM 
recommends consideration for the addition of drugs 
such as enoximone, milrinone, vasopressin, terlipressin 
or angiotensin according to the hemodynamic profile 
while only vasopressin and milrinone were used by the 
responders. Use of these drugs is supported by small case 
series of pediatric patients.
For the ACCM, the use of CRRT in septic shock 
patients without another clear indication for renal 
replacement (e.g., hyperkalemia, severe metabolic aci-
dosis or pulmonary edema with anuria) is indicated in 
patients who have been adequately fluid resuscitated 
but cannot subsequently maintain even-fluid balance 
through native urine output. While HVHF might be ben-
eficial through rapid metabolic stabilization and cytokine 
removal, the increased dose of dialysis may confer sev-
eral risks to a septic shock patient such as hemodynamic 
instability, increase in antibiotic clearance [30], increase 
in venous capacitance and metabolic disorders such as 
hypophosphatemia [31] and delayed renal recovery [32]. 
The benefit of HVHF in septic shock is not supported by 
any large randomized study in adults [33]. No controlled 
study has evaluated this technique in pediatric patients 
[34], meanwhile it was largely put forward in our survey.
The ACCM recommends the use of VA-ECLS in cases 
of refractory septic shock, which is defined by shock not 
reversed despite management with catecholamines in the 
absence of pericardial effusion, pneumothorax or intra-
abdominal hypertension. The main limit of ACCM rec-
ommendation is the absence of a validated definition of 
refractory septic shock. The ESPNIC Refractory Septic 
Shock task force has established a definition based on 
vasopressor-inotrope score, lactate and cardiac dysfunc-
tion or arrest [12]. However, the best timing of initiation 
of VA-ECLS is unknown.
This study has several limitations. Firstly, the clini-
cal vignettes were not validated prior to distribution to 
ensure that interpretations by the readers were in line 
with the expectations of the authors [35]. Secondly, it is 
a regional society survey. Most respondents were from 
European and other high-income countries, making 
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it hard to extrapolate to low- or middle-income coun-
tries. Thirdly, the actual guidelines may have clear rec-
ommendations, but they are not founded on very strong 
evidence. Fourthly, our survey may not explore the 
unlimited possibilities of presentation of septic shock 
patients. Despite our best try to minimize this effect, 
a survey is declarative and the management stated 
here may not reflect routine management. Lastly, the 
responders are mainly intensive care physicians that 
may have be off-setting initial management of septic 
shock patient in the emergency room. This study’s main 
strength is his high response rate and the large panel of 
respondents representing more than 80 PICUs. Addi-
tionally, we analyzed answers obtained from theoreti-
cal and clinical case-based situations in order to best fit 
actual practices.
In the absence of clear evidence, the current guidelines 
are predominantly based on expert opinion and low-
quality retrospective, or observational studies, with a lack 
of high-quality multicenter RCT data. While waiting for 
the pediatric revision of the SSC, a pragmatic approach 
in the care of a sick child remains the cornerstone of cur-
rent septic shock management and may lead to variability 
in care. Future implementation of recommendation into 
sepsis bundles, either in or outside the PICU, requires the 
specific contextualization of the clinical setting that take 
in consideration the patient, the timing and the global 
resources.
Conclusions
This pediatric septic shock management survey outlined 
variability in the current clinician-reported practice of 
pediatric septic shock management. These differences 
may result from evidences reported in adult and pediat-
ric literature as well as physicians’ practices in the pres-
ence of lower grading of pediatric evidence and the lack 
of clear recommendations from the current guidelines. 
We think that five topics need to be addressed in priority: 
restrictive versus liberal fluid strategy, non-invasive and/
or high-flow oxygen therapy, indication and modalities of 
CRRT, indication and timing of VA-ECLS and use of nor-
epinephrine as first-line vasopressor.
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